Product Code: ETC9625709 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Obesity Treatment Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Obesity Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Obesity Treatment Market - Industry Life Cycle |
3.4 Taiwan Obesity Treatment Market - Porter's Five Forces |
3.5 Taiwan Obesity Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Obesity Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Taiwan Obesity Treatment Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Taiwan Obesity Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity in Taiwan |
4.2.2 Growing awareness about the health risks associated with obesity |
4.2.3 Rising disposable income leading to higher spending on healthcare |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for obesity treatment in Taiwan |
4.3.2 Cultural factors influencing attitudes towards weight and weight loss |
4.3.3 Lack of access to specialized obesity treatment facilities |
5 Taiwan Obesity Treatment Market Trends |
6 Taiwan Obesity Treatment Market, By Types |
6.1 Taiwan Obesity Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Obesity Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Taiwan Obesity Treatment Market Revenues & Volume, By Biliopancreatic diversion with Duodenal Switch (BPD/DS), 2021- 2031F |
6.1.4 Taiwan Obesity Treatment Market Revenues & Volume, By Adjusting Gastric Banding, 2021- 2031F |
6.1.5 Taiwan Obesity Treatment Market Revenues & Volume, By Roux-en-Y Gastric Bypass, 2021- 2031F |
6.1.6 Taiwan Obesity Treatment Market Revenues & Volume, By Sleeve gastrectomy, 2021- 2031F |
6.1.7 Taiwan Obesity Treatment Market Revenues & Volume, By Endoscopic Procedures, 2021- 2031F |
6.2 Taiwan Obesity Treatment Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Obesity Treatment Market Revenues & Volume, By Appetite suppressants, 2021- 2031F |
6.2.3 Taiwan Obesity Treatment Market Revenues & Volume, By Combination drugs, 2021- 2031F |
6.2.4 Taiwan Obesity Treatment Market Revenues & Volume, By Malabsorption, 2021- 2031F |
6.2.5 Taiwan Obesity Treatment Market Revenues & Volume, By Satiety drugs, 2021- 2031F |
6.3 Taiwan Obesity Treatment Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Obesity Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Taiwan Obesity Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Taiwan Obesity Treatment Market Import-Export Trade Statistics |
7.1 Taiwan Obesity Treatment Market Export to Major Countries |
7.2 Taiwan Obesity Treatment Market Imports from Major Countries |
8 Taiwan Obesity Treatment Market Key Performance Indicators |
8.1 Average BMI (Body Mass Index) of the population |
8.2 Number of obesity-related health complications reported |
8.3 Percentage of healthcare professionals trained in obesity management |
8.4 Adoption rate of new obesity treatment technologies |
8.5 Average waiting time for obesity treatment appointments. |
9 Taiwan Obesity Treatment Market - Opportunity Assessment |
9.1 Taiwan Obesity Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Obesity Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Taiwan Obesity Treatment Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Taiwan Obesity Treatment Market - Competitive Landscape |
10.1 Taiwan Obesity Treatment Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Obesity Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |